Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,423 | -17,745 | -6,600 | -32,654 | -26,954 |
| Depreciation Amortization | 2,367 | 1,627 | 675 | 2,444 | 1,693 |
| Accounts receivable | 548 | 181 | -1,008 | -859 | -916 |
| Accounts payable and accrued liabilities | 1,088 | 715 | 752 | -615 | -54 |
| Other Working Capital | 357 | -1,172 | -2,194 | 6,485 | 6,164 |
| Other Operating Activity | 3,962 | 2,505 | 736 | 5,629 | 3,933 |
| Operating Cash Flow | $-20,101 | $-13,889 | $-7,639 | $-19,570 | $-16,134 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,143 | 3,297 | -301 | -25,774 | -30,393 |
| PPE Investments | -1,347 | -975 | -607 | -8,821 | -7,540 |
| Other Investing Activity | 0 | 0 | 0 | 373 | 0 |
| Investing Cash Flow | $6,796 | $2,322 | $-908 | $-34,222 | $-37,933 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 762 | 762 | 565 | 7,201 | 6,970 |
| Debt Repayment | -416 | N/A | N/A | -1,859 | -1,859 |
| Common Stock Issued | 120 | 47 | 37 | 35,308 | 30,012 |
| Other Financing Activity | 0 | 0 | 0 | 9,954 | 10,326 |
| Financing Cash Flow | $466 | $809 | $602 | $50,604 | $45,449 |
| Exchange Rate Effect | -255 | -349 | -112 | 267 | -31 |
| Beginning Cash Position | 20,272 | 20,272 | 20,272 | 23,193 | 23,193 |
| End Cash Position | 7,178 | 9,165 | 12,215 | 20,272 | 14,544 |
| Net Cash Flow | $-13,094 | $-11,107 | $-8,057 | $-2,921 | $-8,649 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,101 | -13,889 | -7,639 | -19,570 | -16,134 |
| Capital Expenditure | -1,347 | -975 | -607 | -9,006 | -7,617 |
| Free Cash Flow | -21,448 | -14,864 | -8,246 | -28,576 | -23,751 |